Naoum JJ, Chai H, Lin PH et al (2006) Lymphotoxin-a and cardiovascular disease: clinical association and pathogenic mechanisms. Med Sci Monit 12(7):RA121–RA124
CAS
PubMed
Google Scholar
Kuiper J, van Puijvelde GH, van Wanrooij EJ et al (2007) Immunomodulation of the inflammatory response in atherosclerosis. Curr Opin Lipidol 18(5):521–526
Article
CAS
PubMed
Google Scholar
Okopień B, Basiak M, Madej A et al (2006) Markers of inflammatory process in stable and unstable coronary artery disease. Pol Merkur Lekarski 21(121):69–72
PubMed
Google Scholar
Schneider K, Potter KG, Ware CF (2004) Lymphotoxin and LIGHT signaling pathways and target genes. Immunol Rev 202:49–66
Article
CAS
PubMed
Google Scholar
Ware CF (2005) Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 23:787–819
Article
CAS
PubMed
Google Scholar
Spahn TW, Eugster HP, Fontana A et al (2005) Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway. Infect Immun 73:7077–7088
Article
CAS
PubMed
Google Scholar
Madamanchi NR, Tchivilev I, Runge M (2006) Genetic markers of oxidative stress and coronary atherosclerosis. Curr Atheroscler Rep 8(3):177–183
Article
CAS
PubMed
Google Scholar
Anderson JL, Adams CD, Antman EM et al (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American college of cardiology/American heart association task force on practice guidelines (Writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction): developed in collaboration with the American college of emergency physicians, the society for cardiovascular angiography and interventions, and the society of thoracic surgeons: endorsed by the American association of cardiovascular and pulmonary rehabilitation and the society for academic emergency medicine. Circulation 116(7):e148–e304
Article
PubMed
Google Scholar
Antman EM, Anbe DT, Armstrong PW et al (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American college of cardiology/American heart association task force on practice guidelines (Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). Circulation 110(9):e82–e292
PubMed
Google Scholar
Gibbons RJ, Abrams J, Chatterjee K et al (2003) ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American college of cardiology/American heart association task force on practice guidelines (Committee on the management of patients with chronic stable angina). Circulation 107(1):149–158
Article
PubMed
Google Scholar
Grupo de Trabajo para el Tratamiento de la Hipertensión Arterial de la Sociedad Europea; Sociedad Europea de Cardiología, Mancia G et al (2007) ESH/ESC 2007 guidelines for the management of arterial hypertension. Rev Esp Cardiol 60(9):968.e1–e94
Google Scholar
Ozaki K, Ohnishi Y, Iida A et al (2002) Functional SNPs in the lymphotoxin alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 32(4):650–654
Article
CAS
PubMed
Google Scholar
Kimura A, Takahashi M, Choi BY et al (2007) Lack of association between LTA and LGALS2 polymorphisms and myocardial infarction in Japanese and Korean populations. Tissue Antigens 69(3):265–269
Article
CAS
PubMed
Google Scholar
Sedlacek K, Neureuther K, Mueller JC et al (2007) Lymphotoxin-α and galectin-2 SNPs are not associated with myocardial infarction in two different German populations. J Mol Med 85(9):997–1004
Article
CAS
PubMed
Google Scholar
Clarke R, Xu P, Bennett D et al (2006) Lymphotoxin-a gene and risk of myocardial infarction in 6, 928 cases and 2, 712 controls in the ISIS case–control study. PLoS Genet 2(7):0990–0996
Article
CAS
Google Scholar
Yamada A, Ichihara S, Murase Y et al (2004) Lack of association of polymorphisms of the lymphotoxin alpha gene with myocardial infarction in Japanese. J Mol Med 82:477–483
CAS
PubMed
Google Scholar
Asselbergs FW, Pai JK, Rexrode KM et al (2007) Effects of lymphotoxin-alpha gene and galectin-2 gene polymorphisms on inflammatory biomarkers, cellular adhesion molecules and risk of coronary heart disease. Clin Sci (Lond) 112(5):291–298
Article
CAS
Google Scholar
Koch W, Hoppmann P, Michou E et al (2007) Association of variants in the BAT1-NFKBIL1-LTA genomic region with protection against myocardial infarction in Europeans. Human Mol Genet 16:1821–1827
Article
CAS
Google Scholar
Jang Y, Koh SJ, Kim OY et al (2007) Effect of the 252A > G polymorphism of the lymphotoxin-α gene on inflammatory markers of response to cigarette smoking in Korean healthy men. Clin Chim Acta 377(1–2):221–227
Article
CAS
PubMed
Google Scholar
Zondervan K, Cardon LR et al (2004) The complex interplay among factors that influence allelic association. Nat Rev Genet 5:89–100
Article
CAS
PubMed
Google Scholar
Marchini J, Cardon LR, Phillips MS et al (2004) The effects of human population structure on large genetic association studies. Nat Genet 36:512–517
Article
CAS
PubMed
Google Scholar